About Cultex
Cultex Laboratories GmbH was formed in July 2007 by Prof. Dr. Ulrich Mohr and Prof. Dr. Michaela Aufderheide, to further advance their activities in the in-vitro toxicology sector. Both founders have outstanding track records in cutting edge research, development and implementation relating to the in-vitro analysis of airborne gases, volatile compounds and complex mixtures with a special focus on "real" exposure situations.
Cultex specializes in in-vitro studies, owns the patents of the Cultex in-vitro exposure systems, and continuously improves and optimizes these systems and the techniques based on the experimental results of such in-vitro studies. The Cultex systems, e.g. CULTEX® RFS, have been used in all kinds of in-vitro research and studies. Cultex is able to offer its clients a full service spectrum spanning advice, planning and execution – underpinned by the development of new techniques within in-vitro toxicology with special emphasis on inhalation toxicology.
The company is headquartered at the Medical Park Hannover / Northern Germany. For more information, please refer to http://www.cultex-laboratories.com/
